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ABSTRACT
Objective. To investigate the preva-
lence of ultrasonographic (US) shoul-
der abnormalities in patients with rheu-
matoid arthritis (RA) and to investigate 
the relationship between US findings 
and demographic and clinical features.
Methods. Consecutive patients attend-
ing the rheumatology units involved in 
this study were enrolled. Clinical and 
demographical data were recorded. US 
of bilateral shoulders was performed 
at the same time, examining tendons, 
bursae, gleno-humeral and acromion-
clavicular joints. The presence of signs 
of inflammation, bone erosions or rota-
tor cuff pathology was evaluated.
Results. A total of one hundred pa-
tients were enrolled, mean age (SD) 
59.6 (14.7) years, median disease du-
ration (IQR) 56.5 (34.7, 96.5) months, 
98% of them were on DMARDs and 
22% on biologics. Shoulder tenderness 
was reported by 44% of patients. 34% 
of patients showed at least one sign of 
inflammatory involvement, and 25% of 
them presented with humeral head ero-
sions. Signs of rotator cuff pathology 
were seen in 49% of patients. Agree-
ment between the presence of spon-
taneous pain and US inflammatory 
abnormalities was moderate (kappa 
0.501). Patients with inflammatory in-
volvement of the shoulders had signifi-
cantly higher DAS28, HAQ, VAS pain, 
acute phase reactants and disease du-
ration compared to patient with no in-
flammatory signs, they were more fre-
quently RF positive and reported more 
frequently spontaneous pain.
Conclusion. US assessment of the 
shoulder in RA patients can be con-
sidered of value, especially in patients 
with relevant indicators of disease ac-
tivity and severity.
Introduction
Rheumatoid arthritis (RA) is a chronic 
inflammatory disease that involves 
mainly synovial joints. The natural his-
tory of RA includes persistent joint in-
flammation leading to the deterioration 
of articular structures and to the subse-
quent development of irreversible dis-
ability (1). 
Although the disease more frequently 
involves small joints, large joint in-
volvement is not uncommon, and this 
has been related to higher levels of dis-
ability and poor outcome (2, 3). In RA, 
shoulder involvement is common, with 
several structures that can be targeted 
by the disease and with an impact on 
physical function (4, 5). The gleno-
humeral joint (GHJ) can be involved, 
but also periarticular structures such 
as the long head of the biceps tendon 
(LHBT) or the subacromial/subdeltoid 
bursa (SAD) can undergo inflammatory 
processes.
In the literature, up to 5% of patients 
after 2 years and 96% after 12 years 
showed erosive damage at the shoulder 
(6, 7). Nevertheless, only a small pro-
portion of patients has clinically detect-
able shoulder tenderness (18.5%) and 
swelling (8).
Clinical evaluation of the shoulder does 
not allow an accurate assessment of this 
structure (9). In a study performed on 
50 patients with RA, a poor relationship 
between effusion detected on physical 
examination and confirmed by ultra-
sonography (US) was demonstrated, 
with a kappa value of 0.202 (10).
Musculoskeletal US has proved to be a 
valid tool in the assessment of inflam-
matory arthritis, including RA (11, 12). 
US has proved to be more sensitive than 
clinical examination (13) and has also 
shown responsiveness to change, along 
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with clinical and laboratory measures 
(14). 
A study examining the agreement be-
tween US and MRI of shoulder find-
ings demonstrated a high agreement on 
erosions, moderate agreement on grey-
scale (GS) findings, depending on the 
structure examined, and higher agree-
ment for power Doppler (PD) findings 
(15). In the context of the evaluation 
of a US score based on large joints, GS 
shoulder abnormalities decreased sig-
nificantly after the institution of effica-
cious treatment, while PD did not (16).
The aim of the present study was to 
evaluate the frequency of US-detect-
able abnormalities in the shoulders of 
patients with RA, taking into account 
inflammatory alterations, signs of bone 
damage and of rotator cuff pathology. In 
particular, the correlation between in-




A total of 100 patients with RA, classi-
fied according to the 1987 ACR (17) or, 
alternatively, the 2010 ACR/EULAR 
classification criteria (18), attending 
four outpatients rheumatology clinics 
in Italy, were consecutively enrolled. 
Patients with severe shoulder trauma-
tism and joint surgery were excluded 
from this study. An expert rheumatolo-
gist evaluated patients in each center, 
collecting clinical and laboratory data 
and performing a joint count on 28 
joints and calculating DAS28 (19). 
Moreover, the presence of spontane-
ous joint tenderness and pain during 
acromion-clavicular palpation were 
recorded. Provocative maneuvers (the 
Hawkins, Jobe, Patte, Gerber, and 
Speed tests) were performed as well 
(20). All patients gave written consent 
before the inclusion in the study, which 
was conducted according to the princi-
ples of the Declaration of Helsinki.
Ultrasonographic evaluation
US assessment was carried out at each 
centre by a single experienced operator 
who was blinded to clinical findings, 
in the same day of clinical evaluation. 
Before the beginning of the study, all 
operators reached an agreement on 
both the scanning technique and the 
definition of pathology. The scanning 
technique was defined based on in-
ternational indications and guidelines 
(21-25). US examinations were carried 
out using a MyLab 70 scanner (Esaote 
SpA, Genoa, Italy) equipped with a 
linear multifrequency probe, operating 
at 4-13 MHz, and a a Logiq 9 machine 
(General Electrics Medical Systems, 
Milwaukee, WI, USA) with a linear 
probe operating at 9-14 MHz.
Articular and peri-articular shoulder 
structures were examined, in particular 
the SAD bursa, the sheath of the LHBT, 
the axillary and posterior recesses of the 
GHJ and the acromion-clavicular joint 
(ACJ) were examined for the presence 
of synovial effusions (SE) and synovial 
hypertrophy (SH). Power Doppler (PD) 
assessment of the synovial sites, in-
cluding LHBT, the SAD bursa, and the 
GHJ, was carried out under standard-
ised settings (pulse repetition frequency 
750 Hz, Doppler frequency 7.5 MHz, 
low wall filters, gain at the level that 
avoided random noise artifacts). For 
analysis purposes, inflammatory altera-
tions were defined as presence of effu-
sion, synovial hypertrophy or PD at the 
GHJ, LHBT and SAD bursa. ACJ was 
not evaluated in this context, since ab-
normalities at this level are frequently 
seen even in healthy subjects and might 
not reflect RA involvement (26).
Moreover, the ACJ was examined for 
osteophytes as well as fibrocartilage 
calcifications and the GHJ for the as-
sessment of labrum calcifications and 
erosions, the presence of PD signal 
within the erosion was also evaluated.
The supraspinatus, infraspinatus, sub-
scapularis tendons were also examined, 
to evaluate the presence of rotator cuff 
pathology. In particular, the presence 
of tendinosis, partial or total tendon 
tears and calcifications was assessed. 
Finally, the greater and lesser tuberos-
ity regions were analysed for the pres-
ence of local enthesophytes.
Statistical analysis
Descriptive results are reported as abso-
lute and relative frequency for categor-
ical data, and as median (IQR) or mean 
(SD) according to their distribution. 
Concordance between clinical and US 
shoulder involvement was calculated 
by unweighted kappa-statistics. The as-
sociation between US involvement and 
clinical variables was systematically 
investigated. Categorical variables 
were analysed using chi-squared tests, 
quantitative variables were analysed 
using the unpaired t-test for normally 
distributed, and Mann-Whitney U-test 
for non-normally distributed variables. 
All analyses were performed using 
MedCalc Statistical Software version 
12.7.7 (MedCalc Software bvba, Os-
tend, Belgium, 2013).
Results
In total, 100 patients were included in 
this study and 200 shoulders evalu-
ated. Patients had a mean age (SD) of 
59.6 (14.7), a median disease duration 
of 56.5 months, 74% of them were fe-
male (Table I). The majority of patients 
(98%) were on DMARDs, and 22% of 
them were treated with biologics, in 
particular 18% with a TNF-α inhibitor 
and 4% with tocilizumab. One patient 
was receiving intravenous immuno-
Fig. 1. a. Subdeltoid bursitis (asterisk). b. Supraspinatus tendon tear (arrow). lhbt: long head of the 
biceps tendon; st: supraspinuatus tendon; d: deltoid; h: humerus.
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globulins. Corticosteroids were given 
to 55% of patients, but the majority of 
them (46% over the entire cohort) were 
given low dose steroids (≤5 mg/day), 
with a median dose of 2.5 mg/day; 18 
patients were taking NSAIDs.
Spontaneous joint pain was reported 
by 44% of patients, while 30% of pa-
tients reported pain during the palpa-
tion of the ACJ; provocative maneu-
vers were positive in 46% of patients.
Table II summarises the main inflam-
matory findings found in our popu-
lation. In particular, 19 patients pre-
sented with inflammatory involvement 
of the LHBT, 22 with inflammatory 
abnormalities of the SAD bursa and 14 
with involvement of the GHJ. In total, 
34 patients presented with at least one 
inflammatory alteration at these sites. 
In 25 patients erosions of the humeral 
head, with dimensions ranging from 
0.6 to 10 mm, were found, in 5 of them 
PD signal was detectable within the 
erosion.
ACJ presented inflammatory altera-
tions in 40 patients, but at this site os-
teophytes and degenerative abnormali-
ties were detected in 51 patients, with 
calcifications seen in 4 patients.
US alterations indicative of cuff rota-
tor pathology are summarised in Ta-
ble III. Cuff rotator alterations were 
not uncommon, since 49 patients pre-
sented with at least a single abnormal-
ity, supraspinatus tendinosis being the 
most frequent (41 patients), while sub-
scapularis and infraspinatus tendinosis 
were found in 23 and 14 patients, re-
spectively. Calcifications occurred in 
the context of the supraspinatus in 13 
patients (with dimensions ranging from 
0.2 to 7.2 mm), in the subscapularis in 
11 patients (0.2–7.4 mm) and in the in-
fraspinatus in 3 (0.4–1 mm). Acoustic 
shadowing occurred in 2 cases at the 
subscapularis and 1 case at the infraspi-
natus calcification. Tendon tears oc-
curred more frequently at supraspinatus 
(14 patients), with 4 patients presenting 
with a complete tear, which was bilat-
eral in 3 cases. The infraspinatus was 
torn in 8 patients and the subscapularis 
in 4, with a single case of complete tear 
for both tendons.
Calcifications at the greater tuberos-
ity were found in 6 patients, while 
calcification at the lesser tuberosity in 
5. Labrum calcification was seen in 2 
patients, while humeral head hyaline 
cartilage calcifications were not found.
The agreement between the presence 
of spontaneous pain and the detection 
of US inflammatory findings was mod-
erate, with a kappa (95% CI) of 0.501 
(0.327, 0.675). 
When we evaluated the correlation be-
tween the main clinical findings and the 
presence of inflammatory abnormali-
ties, patients with US inflammatory in-
volvement had a longer median disease 
duration, were more frequently RF pos-
itive, had a higher disease activity and 
higher acute phase reactants, a higher 
level of disability and more pain, with 
an increased frequency of spontaneous 
shoulder pain and higher median VAS 
pain. On the other hand, age, gender, 
ACPA positivity were not significantly 
Table I. Baseline characteristics of patients. 
Patients (n)  100
Age, mean (SD)  59.6 (14.7)
Male/female (n)  26/74
Disease duration, months, median (IQR) 56.5 (34.7,96.5)
DAS28, mean (SD)  3.31 (1.44)
HAQ, median (IQR)  0.75 (0,1.25)
VAS pain, cm, mean (SD)  3.52 (2.8)
RF, n (%)  61 (61)
ACPA, n (%)  47 (47)
ESR mm/h, mean (SD)  22.23 (15.8)
CRP mg/dl, mean (SD)  0.42 (0.44)
DMARDs, n (%)  98 (98)
Corticosteroids, n (%)  55 (55)
Corticosteroid dose, mg, median (IQR) 2.5 (0,5)
Biologics, n (%)  22 (22) 
      TNFi, n (%)  18 (18)
      TCZ,  n (%)  4 (4)
NSAIDs,  n (%)  18 (18)
Shoulder pain, n (%)  44 (44)
Positive provocative maneuvers, n (%) 46 (46)
DAS28: disease activity score on 28 joints; HAQ: health assessment questionnaire; RF: rheumatoid 
factor; ACPA: anti-citrullinated peptide antibodies; ESR: erythrosedimentation rate; CRP: C-reactive 
protein; DMARDs: disease-modifying anti-rheumatic drugs; TNFi: TNF-α inhibitors; TCZ: tocilizum-
ab; NSAIDs: non-steroideal anti-inflammatory drugs.
Table II. Prevalence of inflammatory findings in the shoulder. Data referring to the number 
of shoulders examined are presented.
 Right (n=100) Left (n=100) Total (n=200)
Long head of the biceps tendon   
Effusion 28 16 44 (22%)
Hypertrophy 5 4 9 (4.5%)
Power Doppler 4 3 7 (3.5%)
Subdeltoid bursa   
Effusion 18 7 25 (12.5%)
Hypertrophy 8 3 11 (5.5%)
Power Doppler 8 3 11 (5.5%)
Subscapularis bursa   
Effusion 4 3 7 (3.5%)
Hypertrophy 1 0 1 (0.5%)
Power Doppler 0 0 0 (0%)
Glenohumeral joint   
Effusion 9 7 16 (8%)
Hypertrophy 4 1 5 (2.5%)
Power Doppler 1 0 1 (0.5%)
Acromion-clavicular joint   
Effusion 34 25 59 (29.5%)
Hypertrophy 10 7 17 (8.5%)
Power Doppler 5 1 6 (3%)
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different among the two groups. To test 
the robustness of these findings, tak-
ing into account that effusion can also 
occur in rotator cuff pathology, a more 
stringent definition of inflammatory US 
alterations was applied, considering 
only patients with evidence of syno-
vial hypertrophy and eventually PD. 
This small subgroup of only 15 patients 
had still significantly longer disease 
duration, higher DAS28, HAQ, VAS 
pain, ESR and reported more frequent-
ly spontaneous shoulder tenderness. 
Moreover, in this group, the proportion 
of males was higher (Table IV).
Discussion
With the introduction of new treatments 
and new treatment strategies, the cur-
rent aim in the treatment of RA is the 
achievement of low-disease status and 
eventually remission (27). In this con-
text, a reliable assessment of disease 
activity is needed in order to modulate 
therapy. While several joints and syno-
vial sites are easily accessible by clini-
cal examination, larger joints, such as 
the hips and the shoulders (26, 28, 29), 
cannot be evaluated easily. Since US 
has proven to be reliable in the detec-
tion of subclinical activity, its applica-
tion in the evaluation of large joints 
might be helpful to evaluate disease 
activity.
In this study a population of patients 
with RA has been evaluated clinically 
and by US. The prevalence of inflam-
matory findings at the GHJ, LHBT 
and SAD and subscapularis bursae 
was higher than recently reported in a 
sample of healthy subjects (26). In par-
ticular PD was not detected in healthy 
controls, while RA patients showed the 
presence of PD in some synovial sites. 
In our populations, PD was detected in 
only one GHJ, but this is likely due to 
PD limitations related to the size and 
the depth of the joint. Moreover, the 
majority of patients included in this 
cohort had a long disease duration and 
was taking effective treatment at the 
time of evaluation and this might have 
determined an overall low frequency of 
PD. For the same reasons, although the 
detection of humeral head erosions was 
not uncommon in our population, only 
a minority of patients presented with 
active lesions showing PD, while in 
most of them this was probably a sign 
of previous disease activity. Otherwise, 
we may hypothesise that some of these 
bone erosions were not a pathological 
findings. Of note, Schmidt et al. found 
bone erosions of >1 mm at the humeral 
head in almost 25% of shoulders in 102 
healthy subjects (30).
On the other hand, the involvement of 
the tendons of the rotator cuff was not 
uncommon in patients with RA and 
tended to occur more frequently on the 
dominant side. The frequency of in-
fraspinatus and subscapularis involve-
ment in our population was similar to 
that recently reported in a population 
of healthy subjects of corresponding 
age (26). However, supraspinatus tears 
were more frequent in RA patients, and 
this might be explained by the use of 
systemic or even local corticosteroids 
in this group.
At the level of ACJ, effusion was seen 
with comparable frequencies compared 
to healthy controls with similar age, al-
though RA patients had more frequent-
ly synovial hypertrophy at this level 
and a minority of them also showed PD 
signal, which was not present in healthy 
subjects. Osteophytes were seen in RA 
patients with comparable frequencies 
to the healthy population (26). These 
findings suggest a role of US in detect-
Table III. Prevalence of rotator cuff involvement in the shoulder. Data referring to the 
number of shoulders examined are presented.
 Right (n=100) Left (n=100) Total (n=200)
Supraspinatus tendon   
Tendinopathy 37 24 61 (30.5%)
Calcification 14 11 25 (12.5%)
Tear  12 10 22 (11%)
Infraspinatus tendon   
Tendinopathy 13 6 19 (9.5%)
Calcification 0 1 1 (0.5%)
Tear  8 1 9 (4.5%)
Subscapularis tendon   
Tendinopathy 18 13 31 (15.5%)
Calcification 4 8 12 (6%)
Tear  3 4 7 (3.5%)
Table IV. Correlation between US inflammatory findings and clinical features.
 
 No US US p No US US p
 inflammatory Inflammatory  synovial synovial
 abnormalities abnormalities  hypertrophy hypertrophy
 (n=66)  (n=34)     (n=85)  (n=15) 
Age  59.24 (15.38) 59.65 (14.68) 0.86 59.75 (14.87) 59.6 (14.07) 0.86
  years, mean (SD)
Male gender, n (%) 20 (30.3) 6 (17.6) 0.26 21 (24.7) 5 (33.3) 0.038
Disease duration, 48 (36, 57.4) 90 (61.1, 116.2) 0.0001 48 (36.9, 58) 108 (72, 194.4) 0.0002 
  months, median (IQR) 
RF, n (%) 34 (51.5) 27 (79.4) 0.01 48 (56.4) 13 (86.7) 0.189
ACPA, n (%) 30 (45.4) 17 (50) 0.82 39 (45.9) 8 (53.3) 0.80
DAS28, mean (SD) 2.91 (1.28) 4.08 (1.42) 0.0001 3.10 (1.29) 4.47 (1.68) 0.0005
HAQ, median (IQR) 0.5 (0,1.125) 1 (0.75, 1.5) 0.0004 0.5 (0, 1.625) 1.1 (1, 1.875) 0.0017
VAS pain, cm  2.44 (2.36) 5.61 (2.42) <0.0001 3 (2.53) 6.46 (2.53) <0.0001 
  mean (SD) 
CRP mg/dl,  0.27 (0.18, 0.34) 0.6 (0.41, 0.81) 0.0002 0.3 (0.23, 0.41) 0.45 (0.16, 1.53) 0.37 
  median (IQR) 
ESR mm/h,  18.90 (14.73) 28.67 (16.02) 0.003 20.89 (14.77) 29.80 (19.62) 0.043
  mean (SD)
Spontaneous pain 17 (25.7) 27 (79.4) <0.0001 31 (36.5) 13 (86.7) 0.0009
  n (%) 
DAS: disease activity score; RF: rheumatoid factor; ACPA: anti-citrullinated peptide antibodies; HAQ: 
Health Assessment Questionnaire; VAS: visual analogue scale; CRP: C-reactive protein; ESR: erythro 
sedimentation rate.
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ing signs of disease activity in the ACJ, 
which is also frequently involved in de-
generative processes (26).
In our cohort we found the agreement 
between spontaneous joint tenderness 
and presence of inflammatory lesions to 
be moderate (kappa 0.501). The agree-
ment was higher that what previously 
reported for clinical evaluation of ef-
fusion, suggesting that clinical history 
could be more reliable than clinical ex-
amination in detecting disease activity 
at this level (10).
When we evaluated the correlation be-
tween some clinical features and the 
presence of inflammatory signs pos-
sibly related to disease activity at the 
shoulders, the presence of such abnor-
malities on US seemed to identify a 
subgroup of patients with more severe 
disease. Patients with inflammatory al-
terations at the shoulders had a higher 
disease activity, as shown by higher 
levels of DAS28, ESR and CRP, and 
carried higher levels of disability, as 
previously reported (2). In our popula-
tion, RF was more frequently detected 
in patients with shoulder involvement, 
while the prevalence of ACPA was 
similar, and this might be due to an 
overall lower rate of ACPA positive 
patients in the cohort. Moreover, the 
presence of local pain and its overall 
intensity, measured by the VAS pain, 
were significantly related to inflamma-
tory shoulder involvement. This results 
were confirmed also by an analysis 
based on a more conservative definition 
of inflammatory US involvement, that 
was meant to include patients in which 
abnormalities would more likely be due 
to RA. This further analysis confirmed 
higher disease activity and disability, 
ESR and pain, while male patients were 
more prevalent. However, the small 
sample size of this cohort has to be tak-
en into account.
These findings are in keeping with pre-
vious works, that identified a relation 
between shoulder involvement and dis-
ease activity and disability (31, 32).
The present study carries some limita-
tions. The cross-sectional design does 
not allow to evaluate the impact of US 
findings on relevant outcomes, and the 
univariate analysis does not take into 
account the potential presence of con-
founders. However, these results based 
on a large population confirm the value 
of US in the assessment of the shoulders 
in RA patients. In this population, US 
findings are related to relevant clinical 
and laboratory parameters. US allows 
the differentiation between degenera-
tive shoulder lesions and signs of dis-
ease activity, and identifies a subgroup 
of patients with higher disease activity 
that could benefit from a more aggres-
sive treatment approach.
References
  1. McINNES IB, O’DELL JR: State-of-the-art: 
rheumatoid arthritis. Ann Rheum Dis 2010; 
69: 1898-906.
  2. SCIRÈ CA, IAGNOCCO A, MEENAGH G et al.: 
Ultrasound imaging for the rheumatologist. 
XXVIII. Impact of sonographic knee joint 
involvement in recent-onset inflammatory 
polyarthritis. Clin Exp Rheumatol 2010; 28: 
449-53.
  3. LINN-RASKER SP, van der HELM-van MIL 
AHM, BREEDVELD FC, HUIZINGA TWJ: 
Arthritis of the large joints—in particular, 
the knee—at first presentation is predictive 
for a high level of radiological destruction of 
the small joints in rheumatoid arthritis. Ann 
Rheum Dis 2007; 66: 646-50.
  4. PETERSSON CJ: Painful shoulders in patients 
with rheumatoid arthritis. Prevalence, clini-
cal and radiological features. Scand J Rheu-
matol 1986; 3: 437-51.
  5. TANAKA E, SAITO A, KAMITSUJI S et al.: 
Impact of shoulder, elbow, and knee joint 
Involvement on assessment of rheumatoid 
arthritis using the American College of 
Rheumatology core data set. Arthritis Rheum 
2005; 53: 864-71.
  6. KUPER HH, van LEEUWEN MA, van RIEL PL 
et al.: Radiographic damage in large joints 
in early rheumatoid arthritis: relationship 
with radiographic damage in hands and feet, 
disease activity, and physical disability. Br J 
Rheumatol 1997; 36: 855-60.
  7. DROSSAERS-BAKKER KW, KROON HM, 
ZWINDERMAN AH, BREEDVELD FC, HAZES 
JM: Radiographic damage of large joints in 
long-term rheumatoid arthritis and its rela-
tion to function. Rheumatology (Oxford) 
2000; 39: 998-1003.
  8. KANAZAWA T, NISHINO J, TOHMA S, TANA-
KA S: Analysis of the affected joints in rheu-
matoid arthritis patients in a large Japanese 
cohort. Mod Rheumatol 2013; 23: 44-9.
  9. NAREDO E, AGUADO P, De MIGUEL E et al.: 
Painful shoulder: comparison of physical 
examination and ultrasonographic findings. 
Ann Rheum Dis 2002; 61: 132-6.
10. LUUKKAINEN R, SANILA MT, LUUKAINEN 
P: Poor relationship between joint swelling 
detected on physical examination and effu-
sion diagnosed by ultrasonography in gleno-
humeral joints in patients with rheumatoid 
arthritis. Clin Rheumatol 2007; 26: 865-7.
11. FILIPPUCCI E, IAGNOCCO A, MEENAGH G 
et al.: Ultrasound imaging for the rheuma-
tologist VII. Ultrasound imaging in rheuma-
toid arthritis. Clin Exp Rheumatol 2007; 25: 
5-10.
12. FILIPPUCCI E, MEENAGH G, Delle SEDIE 
A et al.: Ultrasound imaging for the rheu-
matologist XX. Sonographic assessment of 
hand and wrist joint involvement in rheuma-
toid arthritis: comparison between two- and 
three-dimensional ultrasonography. Clin Exp 
Rheumatol 2009; 27: 197-200.
13. di GESO L, FILIPPUCCI E, RIENTE L et al.: 
Ultrasound imaging for the rheumatologist 
XL. Sonographic assessment of the hip in 
rheumatoid arthritis patients. Clin Exp Rheu-
matol 2012; 39: 1488-90.
14. SCHEEL AK, HERMANN KG, OHRNDORF S 
et al.: Prospective 7 year follow up imaging 
study comparing radiography, ultrasonog-
raphy, and magnetic resonance imaging in 
rheumatoid arthritis finger joints. Ann Rheum 
Dis 2006; 65: 595-600.
15. MONTECUCCO C, TODOERTI M, SAKEL-
LARIOU G, SCIRÈ CA, CAPORALI R: Low-
dose oral prednisone improves clinical and 
ultrasonographic remission rates in early 
rheumatoid arthritis: results of a 12-month 
open-label randomised study. Arthritis Res 
Ther 2012; 14: R112.
16. BRUYN GA, NAREDO E, MOLLER I et al.: 
Reliability of ultrasonography in detecting 
shoulder disease in patients with rheumatoid 
arthritis. Ann Rheum Dis 2009; 68: 357-61.
17. HARTUNG W, KELLNER H, STRUNK J et al.: 
Development and evaluation of a novel ul-
trasound score for large joints in rheumatoid 
arthritis: one year of experience in daily clin-
ical practice. Arthritis Care Res 2012; 64: 
675-82.
18. ARNETT FC, EDWORTHY SM, BLOCH DA 
et al.: The American Rheumatism Associa-
tion 1987 revised criteria for the classifica-
tion of rheumatoidarthritis. Arthritis Rheum 
1988; 31: 315-24.
19. ALETAHA D, NEOGI T, SILMAN AJ et al.: 
2010 Rheumatoid arthritis classification cri-
teria: an American College of Rheumatology/
European League Against Rheumatism col-
laborative initiative. Arthritis Rheum 2010; 
62: 2569-81.
20. PREVOO ML, van RIEL PL, van ‘t HOF MA et 
al.: Validity and reliability of joint indices. 
A longitudinal study in patients with recent 
onset rheumatoid arthritis. Br J Rheumatol 
1993; 32: 589-94.
21. SALAFFI F, CIAPETTI A, CAROTTI M et al.: 
Clinical value of single versus composite 
provocative clinical tests in the assessment 
of painful shoulder. J Clin Rheumatol 2010; 
16: 105-8.
22. WAKEFIELD RJ, BALINT PV, SZKUDLAREK 
M et al.: Musculoskeletal ultrasound includ-
ing definitions for ultrasonographic pathol-
ogy. J Rheumatol 2005; 32: 2485-7.
23. KLAUSER AS, TAGLIAFICO A, ALLEN GM et 
al.: Clinical indications for musculoskeletal 
ultrasound: a Delphi-based consensus paper 
of the European Society of Musculoskeletal 
Radiology. Eur Radiol 2012; 22: 1140-8.
24. JACOBSON JA, SHOULDER US: anatomy, 
technique, and scanning pitfalls. Radiology 
2011; 260: 6-16.
25. WAKEFIELD RJ, BALINT PV, SZKUDLAREK 
842
IMAGING Shoulder ultrasonography in RA / G. Sakellariou et al.
M et al.: Musculoskeletal ultrasound includ-
ing definitions for ultrasonographic pathol-
ogy. J Rheumatol 2005; 32: 2485-7.
26. IAGNOCCO A, FILIPPUCCI E, SAKELLARIOU 
G et al.: Ultrasound imaging for the rheuma-
tologist XLIV. Ultrasound of the shoulder 
in healthy individuals. Clin Exp Rheumatol 
2013; 31: 165-71.
27. SMOLEN JS, ALETAHA D, BIJLSMA JW et al.: 
Treating rheumatoid arthritis to target: rec-
ommendations of an international task force. 
Ann Rheum Dis 2010; 69: 631-7.
28. RIENTE L, Delle SEDIE A, FILIPPUCCI E et 
al.: Ultrasound imaging for the rheumatolo-
gist XLV. Ultrasound of the shoulder in pso-
riatic arthritis. Clin Exp Rheumatol 2013; 31: 
329-33.
29. SAKELLARIOU G, IAGNOCCO A, MEENAGH 
G et al.: Ultrasound imaging for the rheuma-
tologist XXXVII. Sonographic assessment 
of the hip in ankylosing spondylitis patients. 
Clin Exp Rheumatol 2012; 30: 1-5.
30. SCHMIDT WA, SCHMIDT H, SCHICKE B, 
GROMNICA-IHLE E: Standard reference val-
ues for musculoskeletal ultrasonography. Ann 
Rheum Dis 2004; 63: 988-4.
31. SLUNGAARD B, MENGSHOEL AM: Shoul-
der function and active motion deficit in pa-
tients with rheumatoid arthritis. Disabil Re-
habil 2013; 35: 1357-63.
32. SHIDARA K, INOUE E, HOSHI D et al.: 
The influence of individual joint impairment 
on functional disability in rheumatoid ar-
thritis using a large observational database 
of Japanese patients. J Rheumatol 2012; 39: 
476-80.
